What is the main business of Zimar?

The main business activity of Zimar focuses on wholesale of pharmaceutical goods.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on February 28, 2023.

Where is the headquarters located?

The headquarters is located at: Aleje Jerozolimskie 85, 02-001 Warszawa.

Who is on the management board?

The management board consists of: Alyaksei Malysh (Member of the Management Board) and Dzmitry Malysh (President of the Management Board).

What is the share capital?

The share capital of the company is PLN 5,000 (approx. $1,351).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

What revenue was generated?

In 2024, the company generated total revenue of $607,852, representing an increase of 50.8% compared to 2023.

Yes, in 2024 the company was profitable, achieving a net profit of $161,056, meaning the company increased its profit by 50.5%.

What is the largest operating cost?

The largest operating cost category falls under cost of goods and materials sold. This category amounted to $264,736 in 2024, representing 62% of all operating expenses.

Zimarsp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2023-02-28

Share capital

5,000.00 PLN

Registered address

Aleje Jerozolimskie 85/21, 02-001 Warszawa, Poland

Electronic delivery address

AE:PL-13526-92986-CWJJD-14

Financials

Revenue history (in k)

Filing timeliness

Financial statements were filed on time, on average 81 days early.

202521/05/2026
202408/04/2025
202317/04/2024

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 530.21kMedianUSD 1.06mAverageUSD 22.41m

Net profit

This companyUSD 134.09kMedianUSD 37.20kAverageUSD 879.46k

Operating costs

This companyUSD 378.36kMedianUSD 921.66kAverageUSD 21.08m

Assets

This companyUSD 228.40kMedianUSD 609.79kAverageUSD 11.85m

Industry

Authorized Representatives

Alyaksei Malysh – Management Board Member

Dzmitry Malysh – President of the Management Board

Manner of representation

Each member of the management board is authorized to make declarations on behalf of the company independently.

Ownership

Owner	Shares	Share value	Stake
Alyaksei Malyshage 52	75	$1,012.97	75%
Dzmitry Malyshage 44	25	$337.66	25%

Alyaksei Malysh and Dzmitry Malysh hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2023-03-15.

PKO Bank Polski
12 1020 1042 0000 8102 0535 3554
PKO Bank Polski
85 1020 1042 0000 8602 0535 3547
PKO Bank Polski
70 1020 1042 0000 8702 0568 1434

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
Dental Solutionssp. z o.o.	$611,683.37	dentalsolutions.pl
Beauty Care Solutionsp. z o.o.	$391,209.94	ohhira.pl
Aimedicalsp. z o.o.	$240,059.72	aimedical.pl
Vorwarts Pharmasp. z o.o.	$210,138.62	vorwartspharma.pl
Black & Whitesp. z o.o.	$154,866.36	polonus.pl
Osteoprofsp. z o.o.	$72,065.80	osteoprof.pl
THC PharmaS.A.	$39,093.70	thc-pharma.pl
EDGE Pharmasp. z o.o.	$19,855.64	edgepharma.eu
Arcade Internationalsp. z o.o.	$17,817.26	arcade-int.pl
Filicosp. z o.o.	$11,710.75	filico.eu